{'text': 'Janssen’s IMBRUVICA®(ibrutinib) Receives Additional European Commission Approval for the Treatment of Waldenström’s Macroglobulinemia', 'publisher': {'href': 'https://www.multivu.com', 'title': 'MultiVu'}, 'created_at': 'Fri, 10 Jul 2015 07:00:00 GMT', 'description': 'Janssen’s IMBRUVICA®(ibrutinib) Receives Additional European Commission Approval for the Treatment of Waldenström’s Macroglobulinemia  MultiVu', 'url': 'https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZzA4NXVvOTF3UzRVQjVTV1VEeGJ1WjRUS0FqcnFiWTFJcHV4XzNYTGpaQ080ellYSU5RRnFwblBydUNKcUpoSExoZVJaaWpPX1FUZU5IbmNIcEI2bWczeWRGRXQ5VFk1UFJjUVhZQ0FpbHhqT0dJbDF3UkoxZXV5M0VBSE9lSl9F?oc=5&hl=en-US&gl=US&ceid=US:en'}
